Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000066

Senior Vice President, Finance sold 1,587 shares at an average $80.95 ($128,468)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Agarwal Arjun · Senior Vice President, Finance

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-22 Sale : show line 1 in the form 10b5-1 −888 $80.01 $71,049 16,011 D
2026-06-22 Sale : show line 2 in the form 10b5-1 −699 $82.15 $57,419 15,312 D
Open-market sales · 1,587 sh · avg $80.95 · $128,468
Loading xslF345X06/form4.xml…